MARKETS

Company Info

INCOME STATEMENTS

Kilitch Drugs(I) Ltd.

You can view the income statements for the last 5 years.

BSE

Jul 18

444.95 -9.05 ( -1.99%)

Volume 67

Prev. Close 454.00

Open Price 444.95

Today's Low / High

444.95

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

278.16

490.00

NSE

Jul 18

441.15 -9.00 ( -2.00%)

Volume 643

Prev. Close 450.15

Open Price 441.15

Today's Low / High

441.15

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

304.51

500.00

ISIN No	INE729D01010	Market Cap. ( ₹ in Cr. )	771.16	P/BV	3.06	Book Value ( ₹ )	144.30
BSE Code	524500	52 Week High/Low ( ₹ )	500/305	FV/ML	10/1	P/E(X)	29.30
NSE Code	KILITCHBE	Book Closure	15/07/2025	EPS ( ₹ )	15.06	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	198.32	153.61	138.86	112.96	68.13
Other Operating Revenues	0.00	0.77	0.74	1.28	0.39
Total Operating Revenues	198.32	154.37	139.60	114.23	68.52

Other Income	11.16	4.48	2.92	2.91	2.67
Total Revenue	209.48	158.85	142.52	117.14	71.19

EXPENSES
Cost Of Materials Consumed	105.75	79.08	74.53	65.48	36.22
Changes In Inventories Of FG,WIP And Stock-In Trade	-1.17	-0.12	0.23	-0.05	1.09
Employee Benefit Expenses	11.32	10.01	11.73	6.18	5.24
Finance Costs	5.04	5.93	4.92	1.20	0.75
Depreciation And Amortisation Expenses	3.11	3.35	3.55	2.47	1.99
Other Expenses	51.33	41.24	35.54	32.25	20.78
Total Expenses	175.39	139.50	130.50	107.53	66.07

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.09	19.35	12.01	9.61	5.12

Profit/Loss Before Tax	34.09	19.35	12.01	9.61	5.12

Tax Expenses-Continued Operations
Current Tax	9.53	6.37	4.20	3.63	1.67
Deferred Tax	0.00	-0.59	-0.47	-0.23	-0.31
Total Tax Expenses	9.53	5.78	3.73	3.40	1.35
Profit/Loss After Tax And Before ExtraOrdinary Items	24.56	13.58	8.28	6.21	3.77

Profit/Loss From Continuing Operations	24.56	13.58	8.28	6.21	3.77

Profit/Loss For The Period	24.56	13.58	8.28	6.21	3.77

Minority Interest	1.76	1.03	2.17	1.15	-0.10
Consolidated Profit/Loss After MI And Associates	26.32	14.60	10.45	7.37	3.67

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	15.27	9.17	6.71	4.73	2.37
Diluted EPS (Rs.)	0.00	9.17	6.71	4.73	2.37

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	198.32
Other Operating Revenues	0.00
Total Operating Revenues	198.32
Other Income	11.16
Total Revenue	209.48
EXPENSES
Cost Of Materials Consumed	105.75
Changes In Inventories Of FG,WIP And Stock-In Trade	-1.17
Employee Benefit Expenses	11.32
Finance Costs	5.04
Depreciation And Amortisation Expenses	3.11
Other Expenses	51.33
Total Expenses	175.39
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.09
Profit/Loss Before Tax	34.09
Tax Expenses-Continued Operations
Current Tax	9.53
Deferred Tax	0.00
Total Tax Expenses	9.53
Profit/Loss After Tax And Before ExtraOrdinary Items	24.56
Profit/Loss From Continuing Operations	24.56
Profit/Loss For The Period	24.56
Minority Interest	1.76
Consolidated Profit/Loss After MI And Associates	26.32
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	15.27
Diluted EPS (Rs.)	0.00